Tirzepatide Guide
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist that activates two incretin hormone pathways simultaneously. It is FDA-approved for type 2 diabetes as Mounjaro and for chronic weight management as Zepbound, and has demonstrated superior weight loss outcomes compared to semaglutide in head-to-head trials.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
At a Glance
How Tirzepatide Works
Tirzepatide is a "twincretin" that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. GLP-1 activation reduces appetite and slows gastric emptying, while GIP activation enhances insulin secretion, reduces glucagon, and may also act directly on fat tissue to improve metabolism. This dual mechanism produces greater weight loss than GLP-1-only agents like semaglutide.[3][5]
Dosing Schedule
Tirzepatide uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].
Side Effects
Common: nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite, injection site reactions, fatigue. Serious (rare): pancreatitis, gallbladder problems, hypoglycemia (especially with insulin), kidney problems, increased heart rate. Same thyroid tumor precautions as semaglutide apply.[1][3]
This is not a complete list. Consult your healthcare provider or prescriber for full safety information. The complete adverse reaction profile is published in the current FDA prescribing information[1].
Clinical Trial Results
In the SURMOUNT-1 trial (N=2,539), tirzepatide at the 15mg dose achieved an average weight loss of 22.5% over 72 weeks — nearly double the results seen with semaglutide. Participants on 10mg lost an average of 21.4%, and those on 5mg lost 15.0%, all versus 2.5% placebo.[3][4]
Where to Get Tirzepatide
These telehealth providers offer access to tirzepatide or compounded equivalents with online consultations and home delivery.
Editorial score · methodology
Vytora Health
Best for: Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Cost Comparison
Starting prices for compounded GLP-1 medications from top providers, sorted cheapest first. Compounded tirzepatide from licensed 503A and 503B pharmacies is legal under federal compounding law[6], with additional tolerances historically allowed while the molecule has appeared on the FDA Drug Shortage List[7]. Both compounded and brand-name prescriptions are generally FSA/HSA eligible under IRS Publication 502[8]. Prices may vary based on dose and promo availability.
| Provider | Starting Price | |
|---|---|---|
| WellMedRx | $0/mo | Visit |
| Bliv | $99/mo | Visit |
| Enhance MD | $99/mo | Visit |
| Noom Med | $99/mo | Visit |
| YourEra | $99/mo | Visit |
| Framework | $100/mo | Visit |
| Lavender Sky Health | $104/mo | Visit |
| Primary Clinic (Direct GLP) | $110/mo | Visit |
| Loop Health | $125/mo | Visit |
| Trimi Health | $125/mo | Visit |
| Found | $129/mo | Visit |
| Care Clinics | $133/mo | Visit |
| LumiMeds | $133/mo | Visit |
| NewSelf | $144/mo | Visit |
| RxPros | $144.97/mo | Visit |
| Alan Meds | $145/mo | Visit |
| Embody | $149/mo | Visit |
| Factor Health MD | $149/mo | Visit |
| Gala | $149/mo | Visit |
| Ivim Health | $149/mo | Visit |
| Joi + Blokes | $149/mo | Visit |
| MyFastRx | $149/mo | Visit |
| Nalena | $149/mo | Visit |
| Oak | $149/mo | Visit |
| Vitara RX | $149/mo | Visit |
| Mint Med | $159/mo | Visit |
| Gimme Care | $163/mo | Visit |
| Fresh Day Meds | $166/mo | Visit |
| HelloWellness | $166/mo | Visit |
| Ondra Health | $166/mo | Visit |
| Pomegranate Health | $166/mo | Visit |
| Alternate Health Club | $169/mo | Visit |
| Try Ageless | $169/mo | Visit |
| Priority Meds | $171/mo | Visit |
| AmberHealth | $175/mo | Visit |
| Zeuss | $175/mo | Visit |
| GetRelief Rx | $179/mo | Visit |
| Nurx | $179/mo | Visit |
| Cielo | $180/mo | Visit |
| NativeMed | $183/mo | Visit |
| NexLife | $186/mo | Visit |
| WePeptideRx | $189/mo | Visit |
| Eve | $195/mo | Visit |
| Lumen Meds | $195.82/mo | Visit |
| Elara Health and Wellness | $196/mo | Visit |
| Care Bare Rx | $199/mo | Visit |
| Curex | $199/mo | Visit |
| InstaRX | $199/mo | Visit |
| Nova MD | $199/mo | Visit |
| Piper | $199/mo | Visit |
| Precision Telemed | $199/mo | Visit |
| Sesame | $199/mo | Visit |
| Strut Health | $199/mo | Visit |
| Velvet Rx | $199/mo | Visit |
| Vytora Health | $200/mo | Visit |
| BeyondMD | $209/mo | Visit |
| Bodybuilding Health+ | $209/mo | Visit |
| Healthicare | $224/mo | Visit |
| Peak Wellness | $229/mo | Visit |
| PeterMD | $229/mo | Visit |
| Tonik Wellness | $229/mo | Visit |
| Elevated Health | $238/mo | Visit |
| Mochi Health | $238/mo | Visit |
| Obu Health | $239/mo | Visit |
| Vaylen | $239/mo | Visit |
| Navio MD | $247/mo | Visit |
| altRX | $249/mo | Visit |
| Ark Health | $249/mo | Visit |
| Kin Meds | $249/mo | Visit |
| Livv | $249/mo | Visit |
| PauseRX | $249/mo | Visit |
| Tyde Wellness | $249/mo | Visit |
| NP2GO | $250/mo | Visit |
| ReadyRx | $255/mo | Visit |
| Yucca Health | $258/mo | Visit |
| NuvaHealth | $259/mo | Visit |
| Sunlight | $259/mo | Visit |
| Ivy Rx | $275/mo | Visit |
| Joey Med | $275/mo | Visit |
| Claya | $279/mo | Visit |
| Liv Body | $279/mo | Visit |
| Novi | $283/mo | Visit |
| Amble | $289/mo | Visit |
| Levers Health | $296/mo | Visit |
| ReflexMD | $297/mo | Visit |
| RNK Health | $297/mo | Visit |
| TMates | $297/mo | Visit |
| BetterMe Rx | $299/mo | Visit |
| Concierge MD LA | $299/mo | Visit |
| Eden | $299/mo | Visit |
| Emerge Weight Loss | $299/mo | Visit |
| Get Thin MD | $299/mo | Visit |
| GoodRx | $299/mo | Visit |
| Mint Medical Clinic | $299/mo | Visit |
| MyStart Health | $299/mo | Visit |
| NiceRx | $299/mo | Visit |
| OrderlyMeds | $299/mo | Visit |
| ShedRx | $299/mo | Visit |
| Sprout Health | $299/mo | Visit |
| Spry | $299/mo | Visit |
| Arc-1 | $300/mo | Visit |
| AMP Health | $309/mo | Visit |
| PeptidesRx | $309/mo | Visit |
| HydraMed | $319/mo | Visit |
| Freya Meds | $332/mo | Visit |
| Fitish | $339/mo | Visit |
| Invigor Medical | $339/mo | Visit |
| Alloy | $349/mo | Visit |
| CoreAge Rx | $349/mo | Visit |
| Henry Meds | $349/mo | Visit |
| MEDVi | $349/mo | Visit |
| Synergy Rx | $349/mo | Visit |
| WeightCare | $349/mo | Visit |
| Zealthy | $351/mo | Visit |
| Independent Wellness | $379/mo | Visit |
| Breeze Meds | $399/mo | Visit |
| Corsica Health | $399/mo | Visit |
| Direct Meds | $399/mo | Visit |
| Fella Health | $399/mo | Visit |
| Lyfe Rx | $399/mo | Visit |
| OnlineSemaglutide.org | $399/mo | Visit |
| PlushCare | $399/mo | Visit |
| Remedy Meds | $399/mo | Visit |
| Super Healthy Rx | $399/mo | Visit |
| Vyora Wellness | $399/mo | Visit |
| Willow | $399/mo | Visit |
| HeliMeds | $447/mo | Visit |
| Shape Vantage | $599/mo | Visit |
| T2D.com | $999/mo | Visit |
| NowPatient | $1069/mo | Visit |
| Effecty | $1300/mo | Visit |
| Form Health | $1350/mo | Visit |
Related Research on Tirzepatide
Deep-dive articles from our research desk with primary-source trial data, FDA label verification, and editorial analysis.
Frequently Asked Questions
Sources & methodology — as of May 2026
- 1.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 2.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 3.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 4.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 5.ADA — Standards of Care in Diabetes (2025)— American Diabetes Association.
- 6.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 8.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Zepbound · Drugs and brands
- Mounjaro · Drugs and brands
- GLP-1 receptor · Mechanism
- GIP receptor · Mechanism
- Dual agonist · Mechanism
- SURMOUNT-1 · Major trials
- SURMOUNT-OSA · Major trials
- Compounded GLP-1 · Pharmacy and drug forms
- Titration · Dosing